Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning

Raul Andero, Scott Heldt, Keqiang Ye, Xia Liu, Antonio Armario, Kerry J. Ressler

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

Objective: Despite increasing awareness of the many important roles played by brain-derived neurotrophic factor (BDNF) activation of TrkB, a fuller understanding of this system and the use of potential TrkB-acting therapeutic agents has been limited by the lack of any identified smallmolecule TrkB agonists that fully mimic the actions of BDNF at brain TrkB receptors in vivo. However, 7,8-dihydroxyflavone (7,8-DHF) has recently been identifi ed as a specific TrkB agonist that crosses the blood-brain barrier after oral or intraperitoneal administration. The authors combined pharmacological, biochemical, and behavioral approaches in a preclinical study examining the role of 7,8-DHF in modulating emotional memory in mice. Method: The authors first examined the ability of systemic 7,8-DHF to activate TrkB receptors in the amygdala. They then examined the effects of systemic 7,8-DHF on acquisition and extinction of conditioned fear, using specific and wellcharacterized BDNF-dependent learning paradigms in several models using naive mice and mice with prior traumatic stress exposure. Results: Amygdala TrkB receptors, which have previously been shown to be required for emotional learning, were activated by systemic 7,8-DHF (at 5 mg/kg i.p.). 7,8-DHF enhanced both the acquisition of fear and its extinction. It also appeared to rescue an extinction deficit in mice with a history of immobilization stress. Conclusions: These data suggest that 7,8-DHF may be an excellent agent for use in understanding the effects of TrkB activation in learning and memory paradigms and may be attractive for use in reversing learning and extinction deficits associated with psychopathology.

Original languageEnglish (US)
Pages (from-to)163-172
Number of pages10
JournalAmerican Journal of Psychiatry
Volume168
Issue number2
DOIs
StatePublished - Feb 1 2011

Fingerprint

Learning
trkB Receptor
Brain-Derived Neurotrophic Factor
Amygdala
Fear
Aptitude
6,7-dihydroxyflavone
Blood-Brain Barrier
Psychopathology
Immobilization
Pharmacology
Psychological Extinction
Brain
Therapeutics

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health

Cite this

Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. / Andero, Raul; Heldt, Scott; Ye, Keqiang; Liu, Xia; Armario, Antonio; Ressler, Kerry J.

In: American Journal of Psychiatry, Vol. 168, No. 2, 01.02.2011, p. 163-172.

Research output: Contribution to journalArticle

Andero, Raul ; Heldt, Scott ; Ye, Keqiang ; Liu, Xia ; Armario, Antonio ; Ressler, Kerry J. / Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. In: American Journal of Psychiatry. 2011 ; Vol. 168, No. 2. pp. 163-172.
@article{2828714a8b964bd6ba33e1a25e5b5696,
title = "Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning",
abstract = "Objective: Despite increasing awareness of the many important roles played by brain-derived neurotrophic factor (BDNF) activation of TrkB, a fuller understanding of this system and the use of potential TrkB-acting therapeutic agents has been limited by the lack of any identified smallmolecule TrkB agonists that fully mimic the actions of BDNF at brain TrkB receptors in vivo. However, 7,8-dihydroxyflavone (7,8-DHF) has recently been identifi ed as a specific TrkB agonist that crosses the blood-brain barrier after oral or intraperitoneal administration. The authors combined pharmacological, biochemical, and behavioral approaches in a preclinical study examining the role of 7,8-DHF in modulating emotional memory in mice. Method: The authors first examined the ability of systemic 7,8-DHF to activate TrkB receptors in the amygdala. They then examined the effects of systemic 7,8-DHF on acquisition and extinction of conditioned fear, using specific and wellcharacterized BDNF-dependent learning paradigms in several models using naive mice and mice with prior traumatic stress exposure. Results: Amygdala TrkB receptors, which have previously been shown to be required for emotional learning, were activated by systemic 7,8-DHF (at 5 mg/kg i.p.). 7,8-DHF enhanced both the acquisition of fear and its extinction. It also appeared to rescue an extinction deficit in mice with a history of immobilization stress. Conclusions: These data suggest that 7,8-DHF may be an excellent agent for use in understanding the effects of TrkB activation in learning and memory paradigms and may be attractive for use in reversing learning and extinction deficits associated with psychopathology.",
author = "Raul Andero and Scott Heldt and Keqiang Ye and Xia Liu and Antonio Armario and Ressler, {Kerry J.}",
year = "2011",
month = "2",
day = "1",
doi = "10.1176/appi.ajp.2010.10030326",
language = "English (US)",
volume = "168",
pages = "163--172",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "2",

}

TY - JOUR

T1 - Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning

AU - Andero, Raul

AU - Heldt, Scott

AU - Ye, Keqiang

AU - Liu, Xia

AU - Armario, Antonio

AU - Ressler, Kerry J.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Objective: Despite increasing awareness of the many important roles played by brain-derived neurotrophic factor (BDNF) activation of TrkB, a fuller understanding of this system and the use of potential TrkB-acting therapeutic agents has been limited by the lack of any identified smallmolecule TrkB agonists that fully mimic the actions of BDNF at brain TrkB receptors in vivo. However, 7,8-dihydroxyflavone (7,8-DHF) has recently been identifi ed as a specific TrkB agonist that crosses the blood-brain barrier after oral or intraperitoneal administration. The authors combined pharmacological, biochemical, and behavioral approaches in a preclinical study examining the role of 7,8-DHF in modulating emotional memory in mice. Method: The authors first examined the ability of systemic 7,8-DHF to activate TrkB receptors in the amygdala. They then examined the effects of systemic 7,8-DHF on acquisition and extinction of conditioned fear, using specific and wellcharacterized BDNF-dependent learning paradigms in several models using naive mice and mice with prior traumatic stress exposure. Results: Amygdala TrkB receptors, which have previously been shown to be required for emotional learning, were activated by systemic 7,8-DHF (at 5 mg/kg i.p.). 7,8-DHF enhanced both the acquisition of fear and its extinction. It also appeared to rescue an extinction deficit in mice with a history of immobilization stress. Conclusions: These data suggest that 7,8-DHF may be an excellent agent for use in understanding the effects of TrkB activation in learning and memory paradigms and may be attractive for use in reversing learning and extinction deficits associated with psychopathology.

AB - Objective: Despite increasing awareness of the many important roles played by brain-derived neurotrophic factor (BDNF) activation of TrkB, a fuller understanding of this system and the use of potential TrkB-acting therapeutic agents has been limited by the lack of any identified smallmolecule TrkB agonists that fully mimic the actions of BDNF at brain TrkB receptors in vivo. However, 7,8-dihydroxyflavone (7,8-DHF) has recently been identifi ed as a specific TrkB agonist that crosses the blood-brain barrier after oral or intraperitoneal administration. The authors combined pharmacological, biochemical, and behavioral approaches in a preclinical study examining the role of 7,8-DHF in modulating emotional memory in mice. Method: The authors first examined the ability of systemic 7,8-DHF to activate TrkB receptors in the amygdala. They then examined the effects of systemic 7,8-DHF on acquisition and extinction of conditioned fear, using specific and wellcharacterized BDNF-dependent learning paradigms in several models using naive mice and mice with prior traumatic stress exposure. Results: Amygdala TrkB receptors, which have previously been shown to be required for emotional learning, were activated by systemic 7,8-DHF (at 5 mg/kg i.p.). 7,8-DHF enhanced both the acquisition of fear and its extinction. It also appeared to rescue an extinction deficit in mice with a history of immobilization stress. Conclusions: These data suggest that 7,8-DHF may be an excellent agent for use in understanding the effects of TrkB activation in learning and memory paradigms and may be attractive for use in reversing learning and extinction deficits associated with psychopathology.

UR - http://www.scopus.com/inward/record.url?scp=79952728977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952728977&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.2010.10030326

DO - 10.1176/appi.ajp.2010.10030326

M3 - Article

C2 - 21123312

AN - SCOPUS:79952728977

VL - 168

SP - 163

EP - 172

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 2

ER -